Streetbeat News

Products Services

TM

Zubie has entered into an agreement with Toyota's Commercial Vehicle Connectivity Platform, Toyota Data Solutions. This partnership aims to enhance vehicle connectivity and data solutions.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:37 am

BBIO

BridgeBio Pharma has received Breakthrough Therapy Designation from the FDA for its oral drug Infigratinib, which is under development for treating children with achondroplasia. This designation is intended to expedite the drug's development and regulatory review.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:32 am

F

Ford Motor Co is set to launch a limited edition, high-performance street-legal race car variant of the Mustang, the 2025 Ford Mustang GTD, with up to 815 horsepower and a top speed of 202 mph. The car is expected to be available by late 2024 or early 2025, with a starting price of over $300,000.

Portfolio Pulse from Anan Ashraf

September 17, 2024 | 11:26 am

GTN

The New Orleans Pelicans and Gray Media Group have partnered to expand game coverage across the Gulf Coast through a new broadcast network. This collaboration aims to enhance the reach and accessibility of Pelicans games for fans in the region.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:18 am

GSK

Japan's Ministry of Health, Labour and Welfare has accepted GSK's new drug application for Blenrep in combination with other drugs for treating relapsed or refractory multiple myeloma.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:18 am

OIS

SDRL

Seadrill Limited and Oil States International have announced a collaboration to enhance offshore Managed Pressure Drilling (MPD) systems. This partnership aims to improve safety and efficiency by integrating Oil States' MPD Integrated Riser Joint system with Seadrill's drilling vessels.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:17 am

GRMN

Garmin has received certification for its G5000 integrated flight deck for the Cessna Citation XLS+ and XLS Gen2 aircraft. This certification marks a significant milestone for Garmin in expanding its aviation product offerings.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:16 am

SENS

The FDA has cleared Senseonics' Eversense 365, a next-generation continuous glucose monitoring system for people with diabetes. This system is the first of its kind to offer a one-year duration for continuous monitoring.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:15 am

CAH

Telix has chosen Cardinal Health as the distributor for its PET agent Zircaix, used in imaging kidney cancer, in the US. This partnership aims to enhance the distribution of Zircaix, potentially impacting Cardinal Health's operations and market presence.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:14 am

RNAZ

TransCode Therapeutics has dosed the first patients in its Phase 1 trial for TTX-MC138, a novel RNA therapeutic targeting metastatic cancer. The trial aims to assess safety and tolerability, with potential implications for treating various cancers.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:13 am